Literature DB >> 32325157

Protective effects of phenelzine administration on synaptic and non-synaptic cortical mitochondrial function and lipid peroxidation-mediated oxidative damage following TBI in young adult male rats.

Rachel L Hill1, Indrapal N Singh2, Juan A Wang3, Jacqueline R Kulbe3, Edward D Hall2.   

Abstract

Traumatic brain injury (TBI) results in mitochondrial dysfunction and induction of lipid peroxidation (LP). Lipid peroxidation-derived neurotoxic aldehydes such as 4-HNE and acrolein bind to mitochondrial proteins, inducing additional oxidative damage and further exacerbating mitochondrial dysfunction and LP. Mitochondria are heterogeneous, consisting of both synaptic and non-synaptic populations, with synaptic mitochondria being more vulnerable to injury-dependent consequences. The goal of these studies was to explore the hypothesis that interrupting secondary oxidative damage following TBI using phenelzine (PZ), an aldehyde scavenger, would preferentially protect synaptic mitochondria against LP-mediated damage in a dose- and time-dependent manner. Male Sprague-Dawley rats received a severe (2.2 mm) controlled cortical impact (CCI)-TBI. PZ (3-30 mg/kg) was administered subcutaneously (subQ) at different times post-injury. We found PZ treatment preserves both synaptic and non-synaptic mitochondrial bioenergetics at 24 h and that this protection is partially maintained out to 72 h post-injury using various dosing regimens. The results from these studies indicate that the therapeutic window for the first dose of PZ is likely within the first hour after injury, and the window for administration of the second dose seems to fall between 12 and 24 h. Administration of PZ was able to significantly improve mitochondrial respiration compared to vehicle-treated animals across various states of respiration for both the non-synaptic and synaptic mitochondria. The synaptic mitochondria appear to respond more robustly to PZ treatment than the non-synaptic, and further experimentation will need to be done to further understand these effects in the context of TBI.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  4-hydroxynonenal (4-HNE); Acrolein; Lipid peroxidation; Non-synaptic mitochondria; Phenelzine; Synaptic mitochondria; Traumatic brain injury

Mesh:

Substances:

Year:  2020        PMID: 32325157      PMCID: PMC7418938          DOI: 10.1016/j.expneurol.2020.113322

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  149 in total

1.  Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury.

Authors:  Y Xiong; Q Gu; P L Peterson; J P Muizelaar; C P Lee
Journal:  J Neurotrauma       Date:  1997-01       Impact factor: 5.269

2.  Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.

Authors:  Ayman G Mustafa; Juan A Wang; Kimberly M Carrico; Edward D Hall
Journal:  J Neurochem       Date:  2011-03-22       Impact factor: 5.372

3.  4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol) inhibits peroxynitrite-mediated phenol nitration.

Authors:  R T Carroll; P Galatsis; S Borosky; K K Kopec; V Kumar; J S Althaus; E D Hall
Journal:  Chem Res Toxicol       Date:  2000-04       Impact factor: 3.739

Review 4.  Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.

Authors:  P Hemachandra Reddy; Raghav Tripathi; Quang Troung; Karuna Tirumala; Tejaswini P Reddy; Vishwanath Anekonda; Ulziibat P Shirendeb; Marcus J Calkins; Arubala P Reddy; Peizhong Mao; Maria Manczak
Journal:  Biochim Biophys Acta       Date:  2011-10-19

5.  Age-related mitochondrial changes after traumatic brain injury.

Authors:  Lesley K Gilmer; Mubeen A Ansari; Kelly N Roberts; Stephen W Scheff
Journal:  J Neurotrauma       Date:  2010-05       Impact factor: 5.269

Review 6.  Mitochondria in neuroplasticity and neurological disorders.

Authors:  Mark P Mattson; Marc Gleichmann; Aiwu Cheng
Journal:  Neuron       Date:  2008-12-10       Impact factor: 17.173

7.  Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.

Authors:  Ram H Nagaraj; Pratishruti Sarkar; Anirudh Mally; Klaus M Biemel; Markus O Lederer; Pius S Padayatti
Journal:  Arch Biochem Biophys       Date:  2002-06-01       Impact factor: 4.013

8.  Continuous Infusion of Phenelzine, Cyclosporine A, or Their Combination: Evaluation of Mitochondrial Bioenergetics, Oxidative Damage, and Cytoskeletal Degradation following Severe Controlled Cortical Impact Traumatic Brain Injury in Rats.

Authors:  Jacqueline R Kulbe; Indrapal N Singh; Juan A Wang; John E Cebak; Edward D Hall
Journal:  J Neurotrauma       Date:  2018-03-27       Impact factor: 5.269

9.  Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes.

Authors:  J P Bolaños; S Peuchen; S J Heales; J M Land; J B Clark
Journal:  J Neurochem       Date:  1994-09       Impact factor: 5.372

Review 10.  Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses.

Authors:  Andrew F MacAskill; Talia A Atkin; Josef T Kittler
Journal:  Eur J Neurosci       Date:  2010-07       Impact factor: 3.386

View more
  3 in total

1.  Functional resveratrol-biodegradable manganese doped silica nanoparticles for the spinal cord injury treatment.

Authors:  Xue Jiang; Xiaoyao Liu; Qi Yu; Wenwen Shen; Xifan Mei; He Tian; Chao Wu
Journal:  Mater Today Bio       Date:  2021-12-04

2.  Melatonin alleviates traumatic brain injury-induced anxiety-like behaviors in rats: Roles of the protein kinase A/cAMP-response element binding signaling pathway.

Authors:  Ling-Ling Xie; Shan-Shan Li; Yong-Jian Fan; Man-Man Qi; Zhuang-Zhuang Li
Journal:  Exp Ther Med       Date:  2022-01-31       Impact factor: 2.447

Review 3.  Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.

Authors:  Dmitriy Matveychuk; Erin M MacKenzie; David Kumpula; Mee-Sook Song; Andrew Holt; Satyabrata Kar; Kathryn G Todd; Paul L Wood; Glen B Baker
Journal:  Cell Mol Neurobiol       Date:  2021-04-10       Impact factor: 5.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.